Ask AI
ProCE Banner Activity

CLARITY: Comparison of Long-Acting Injectable Antiretrovirals in Healthy Adults Without HIV

Conference Coverage
Slideset

In this small, open-label, randomized crossover study of long-acting injectable antiretrovirals, cabotegravir (CAB) injections were more acceptable than lenacapavir (LEN) injections, with the majority of study participants preferring CAB to LEN.

Released: October 22, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare